Plain-English translation of NCT06807281 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atopic Dermatitis research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a medication called — taken by mouth as a liquid — to see if it is safe and works well for children aged 2 and older who have moderate-to-severe eczema. The study will follow children for up to 2 years, with some children who have already tried this medication in earlier studies, and some children who are trying it for the first time. Researchers will track how well the medication controls eczema symptoms and watch for any side effects.
Severe childhood eczema can be very hard to treat with creams and ointments alone, and children need better treatment options. This study will help doctors understand whether this new oral medication is a safe and effective choice for children whose eczema is not controlled well enough with topical treatments.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will take the liquid medication by mouth regularly for up to 2 years. You will visit the study clinic regularly so doctors can check how your eczema is improving, watch for any side effects, and do routine blood tests. Some children can also use creams or ointments along with the medication if needed. The study will either end after 2 years or when the medication becomes available to buy, whichever comes first.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States